Combined Q-switched Nd:YAG Laser and Platelet Rich Plasma Versus Q- Switched Nd:YAG Laser Alone in Melasma
NCT ID: NCT04765930
Last Updated: 2021-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2019-10-01
2021-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Pilot Study Testing 1064nm Q-switch Laser Versus Glycolic Acid Peels for the Treatment of Melasma
NCT01976273
Study of Acid Peel and Laser for the Treatment of Melasma
NCT00467233
Study of Light Treatment and Laser Treatment for Melasma
NCT00509977
Fractional Erbium YAG Laser vs Intradermal and Systemic Tranexamic Acid
NCT06522984
Combined Low-Dose Isotretenion and Long-Pulsed 1064 ND-YAG Laser in the Treatment of Acne Erythema
NCT05622253
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PRP Injection
Half of the face
Q-switched nd:YAG laser toning
Q-switched nd:YAG laser toning for melasma.
Saline injection
Other half of the face
Q-switched nd:YAG laser toning
Q-switched nd:YAG laser toning for melasma.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Q-switched nd:YAG laser toning
Q-switched nd:YAG laser toning for melasma.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Use of oral or injectable contraceptives or hormone replacement therapy during treatment or 12 months before
* Patients active skin infections and active HSV
* History of hypertrophic scars or keloids.
* Patients with hypercoagulable state or bleeding diatheses
* Pregnant and lactating females.
* History of liver diseases
* Intake of systemic chemotherapy, corticosteroids, antiplatelets or anticoagulants
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mona El-Kalioby
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Dermatology, Cairo University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MelaPRP2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.